8-125024539-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_014846.4(WASHC5):​c.*78A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000316 in 1,131,868 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00039 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00030 ( 2 hom. )

Consequence

WASHC5
NM_014846.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.618

Publications

0 publications found
Variant links:
Genes affected
WASHC5 (HGNC:28984): (WASH complex subunit 5) This gene encodes a 134 kDa protein named strumpellin that is predicted to have multiple transmembrane domains and a spectrin-repeat-containing domain. This ubiquitously expressed gene has its highest expression in skeletal muscle. The protein is named for Strumpell disease; a form of hereditary spastic paraplegia (HSP). Spastic paraplegias are a diverse group of disorders in which the autosomal dominant forms are characterized by progressive, lower extremity spasticity caused by axonal degeneration in the terminal portions of the longest descending and ascending corticospinal tracts. More than 30 loci (SPG1-33) have been implicated in hereditary spastic paraplegia diseases. [provided by RefSeq, Aug 2009]
WASHC5 Gene-Disease associations (from GenCC):
  • Ritscher-Schinzel syndrome 1
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • hereditary spastic paraplegia 8
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Ritscher-Schinzel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 8-125024539-T-C is Benign according to our data. Variant chr8-125024539-T-C is described in ClinVar as [Benign]. Clinvar id is 361708.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000394 (60/152330) while in subpopulation AMR AF = 0.00085 (13/15298). AF 95% confidence interval is 0.000502. There are 1 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASHC5NM_014846.4 linkc.*78A>G 3_prime_UTR_variant Exon 29 of 29 ENST00000318410.12 NP_055661.3 Q12768
WASHC5NM_001330609.2 linkc.*78A>G 3_prime_UTR_variant Exon 28 of 28 NP_001317538.1 E7EQI7
WASHC5XM_047422502.1 linkc.*78A>G 3_prime_UTR_variant Exon 30 of 30 XP_047278458.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASHC5ENST00000318410.12 linkc.*78A>G 3_prime_UTR_variant Exon 29 of 29 1 NM_014846.4 ENSP00000318016.7 Q12768
WASHC5ENST00000519042.2 linkn.697A>G non_coding_transcript_exon_variant Exon 3 of 3 2
WASHC5ENST00000517845.5 linkc.*78A>G 3_prime_UTR_variant Exon 27 of 27 2 ENSP00000429676.1 E7EQI7

Frequencies

GnomAD3 genomes
AF:
0.000394
AC:
60
AN:
152212
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00951
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.000956
GnomAD4 exome
AF:
0.000304
AC:
298
AN:
979538
Hom.:
2
Cov.:
13
AF XY:
0.000333
AC XY:
169
AN XY:
507468
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24216
American (AMR)
AF:
0.000162
AC:
7
AN:
43320
Ashkenazi Jewish (ASJ)
AF:
0.00925
AC:
211
AN:
22804
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37424
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52900
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4830
European-Non Finnish (NFE)
AF:
0.0000653
AC:
44
AN:
673890
Other (OTH)
AF:
0.000811
AC:
36
AN:
44382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000394
AC:
60
AN:
152330
Hom.:
1
Cov.:
32
AF XY:
0.000403
AC XY:
30
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41568
American (AMR)
AF:
0.000850
AC:
13
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00951
AC:
33
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68038
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000416
Hom.:
0
Bravo
AF:
0.000491

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 8 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.7
DANN
Benign
0.66
PhyloP100
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs188863489; hg19: chr8-126036781; API